Exercise Improves V˙O2max and Body Composition in Androgen Deprivation Therapy-treated Prostate Cancer Patients.
作者： BRADLEY A. WALL , DANIEL A. GALVãO , NAEEM FATEHEE , DENNIS R. TAAFFE , NIGEL SPRY
DOI: 10.1249/MSS.0000000000001277
关键词:
摘要: ABSTRACTIntroductionProstate cancer is the most common in men, and patients treated with androgen deprivation therapy (ADT) experience unfavorable changes body composition associated metabolic complications, which can increase risk of cardiovascular disease. We examined effect
murdoch.edu.au参考文章(36)
Atkins N, O'Brien E, Thomas M, Mee F, Evaluation of three devices for self-measurement of blood pressure according to the revised British Hypertension Society Protocol: the Omron HEM-705CP, Philips HP5332, and Nissei DS-175. Blood Pressure Monitoring. ,vol. 1, pp. 55- 61 ,(1996)
Dauzat M, Nottin S, Walther G, Obert P, Vinet A, Beck L, Messner-Pellenc P, Reproducibility of automated pulse wave velocity measurement during exercise. Running head: pulse wave velocity during exercise. Archives Des Maladies Du Coeur Et Des Vaisseaux. ,vol. 99, pp. 564- 568 ,(2006)
Kerri Winters-Stone, Nathan Dieckmann, Gianni Maddalozzo, Jill Bennett, Christopher Ryan, Tomasz Beer, Resistance Exercise Reduces Body Fat and Insulin During Androgen-Deprivation Therapy for Prostate Cancer Oncology Nursing Forum. ,vol. 42, pp. 348- 356 ,(2015) , 10.1188/15.ONF.348-356
Daniel A. Galvão, Dennis R. Taaffe, Resistance Exercise Dosage in Older Adults: Single‐ Versus Multiset Effects on Physical Performance and Body Composition Journal of the American Geriatrics Society. ,vol. 53, pp. 2090- 2097 ,(2005) , 10.1111/J.1532-5415.2005.00494.X
Hendrik Van Poppel, Bertrand Tombal, Cardiovascular risk during hormonal treatment in patients with prostate cancer Cancer management and research. ,vol. 3, pp. 49- 55 ,(2011) , 10.2147/CMR.S16893
S Nicole Culos-Reed, John W Robinson, Harold Lau, Lynette Stephenson, Melanie Keats, Steve Norris, Greg Kline, Peter Faris, None, Physical activity for men receiving androgen deprivation therapy for prostate cancer: benefits from a 16-week intervention. Supportive Care in Cancer. ,vol. 18, pp. 591- 599 ,(2010) , 10.1007/S00520-009-0694-3
Matthew R Smith, Changes in fat and lean body mass during androgen-deprivation therapy for prostate cancer. Urology. ,vol. 63, pp. 742- 745 ,(2004) , 10.1016/J.UROLOGY.2003.10.063
Freerk T. Baumann, Eva M. Zopf, Wilhelm Bloch, Clinical exercise interventions in prostate cancer patients—a systematic review of randomized controlled trials Supportive Care in Cancer. ,vol. 20, pp. 221- 233 ,(2012) , 10.1007/S00520-011-1271-0
Shehzad Basaria, Denis C. Muller, Michael A. Carducci, Josephine Egan, Adrian S. Dobs, Hyperglycemia and insulin resistance in men with prostate carcinoma who receive androgen-deprivation therapy. Cancer. ,vol. 106, pp. 581- 588 ,(2006) , 10.1002/CNCR.21642
S. Basaria, Androgen Deprivation Therapy, Insulin Resistance, and Cardiovascular Mortality: An Inconvenient Truth Journal of Andrology. ,vol. 29, pp. 534- 539 ,(2008) , 10.2164/JANDROL.108.005454